Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 or #4)
Latest & greatest articles for adhd
The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on adhd or other clinical topics then use Trip today.
This page lists the very latest high quality evidence on adhd and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.
What is Trip?
Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.
Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.
As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.
For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via firstname.lastname@example.org
ADHD (or Attention deficit hyperactivity disorder) is a neurodevelopmental type mental disorder. It is characterised two main categories of two types of behavioural problems:
hyperactivity and impulsiveness
Most people with ADHD have problems that fall into both categories, but it doesn’t have to be the case. If a person just has inattentiveness it is referred to as attention deficit disorder (ADD).
Methylphenidate is a commonly used medication used to treat patients suffering from attention-deficit hyperactivity disorder. Methylphenidate is part of a group of drugs known as stimulants. Central nervous system stimulants help change the amounts of natural substances in the brain. But it is not the only intervention; others include Bupropion, exercise and CBT (Cognitive behavioural therapy).
Extensive ADHD research and case studies have been carried out over numerous years. Trip has unrivalled coverage of the evidence base including systematic reviews, clinical trials, clinical guidelines and case studies.
Studies are ongoing to assess the safety and effectiveness of stimulants used on children with ADHD and intellectual disabilities as well as in other populations and other interventions. Trip also includes ongoing controlled trials and ongoing systematic reviews (via the PROSPERO database).
disorder or ADHD Share: Reading time approx. 6 minutes There are theories that different types of nutritional or dietary interventions, where specific food items are excluded from the diet or where nutritional supplements are added, may affect the symptoms of persons with AttentionDeficitHyperactivityDisorder (ADHD) or autism spectrum disorder. This applies, for example, to gluten-free and casein-free diet, ketogenic diet (a strict option of a low carbohydrate diet) or diet where sugar or various (...) ): AHRQ (US Agency for Healthcare Research and Quality); 2018. Catala-Lopez F, Hutton B, Nunez-Beltran A, Page MJ, Ridao M, Macias Saint-Gerons D, et al. The pharmacological and non-pharmacological treatment of attentiondeficithyperactivitydisorder in children and adolescents: A systematic review with network meta-analyses of randomised trials. PLoS One 2017;12:e0180355. Sonuga-Barke EJ, Brandeis D, Cortese S, Daley D, Ferrin M, Holtmann M, et al. Nonpharmacological interventions for ADHD
, Ph.D. AHRQ Publication No. 18-EHC005-EF January 2018 ii Key Messages Purpose of Review To update a previous review by comparing strategies to diagnose, treat, and monitor children and adolescents with attentiondeficithyperactivitydisorder (ADHD). Key Messages • Evidence was insufficient on imaging or electroencephalogram to diagnose ADHD in children 7–17 years of age. • Little evidence adds to the 2011 report that found that methylphenidate is effective for children under age 6 with ADHD (...) . Harvard TH Chan School of Public Health Boston, MA Peter Jensen, M.D. Mayo Clinic Rochester, MN viii AttentionDeficitHyperactivityDisorder: Diagnosis and Treatment in Children and Adolescents Structured Abstract Objectives. Attentiondeficithyperactivitydisorder (ADHD) is a common pediatric neurobehavioral disorder often treated in the primary care setting. This systematic review updates and extends two previous Agency for Healthcare Research and Quality (AHRQ) systematic evidence reviews
Crescenzo , Samuele Cortese , , Nicoletta Adamo , Luigi Janiri Statistics from Altmetric.com Introduction Attention-deficit/hyperactivitydisorder (ADHD) is one of the most common neuropsychiatric conditions, with a pooled worldwide prevalence estimated at about 5% in school-aged children and persistence of impairing symptoms in adulthood in up to 65% of cases. The pooled estimated prevalence of ADHD (as categorical diagnosis) in adults is around 2.5%. ADHD is characterised by a persistent and impairing (...) value of combining pharmacological and non-pharmacological treatments. References Faraone SV , Asherson P , Banaschewski T , et al . Attention-deficit/hyperactivitydisorder . Moffitt TE , Houts R , Asherson P , et al . Is adult ADHD a childhood-onset neurodevelopmental disorder? Evidence from a four-decade longitudinal cohort study . Seixas M , Weiss M , Muller U . Systematic review of national and international guidelines on attention-deficithyperactivitydisorder . Thapar A , Cooper M
Social skills training for attentiondeficithyperactivitydisorder (ADHD) in children aged 5 to 18 years. Attentiondeficithyperactivitydisorder (ADHD) in children is associated with hyperactivity and impulsivity, attention problems, and difficulties with social interactions. Pharmacological treatment may alleviate the symptoms of ADHD but this rarely solves difficulties with social interactions. Children with ADHD may benefit from interventions designed to improve their social skills. We (...) examined the benefits and harms of social skills training on social skills, emotional competencies, general behaviour, ADHD symptoms, performance in school of children with ADHD, and adverse events.To assess the beneficial and harmful effects of social skills training in children and adolescents with ADHD.In July 2018, we searched CENTRAL, MEDLINE, Embase, PsycINFO, 4 other databases and two trials registers.We also searched online conference abstracts, and contacted experts in the field
Attention-DeficitHyperactivityDisorder 1 Quality Department Guidelines for Clinical Care Ambulatory ADHD Guideline Team Team Leaders John M O'Brien, MD Family Medicine Jennifer G. Christner, MD Child Behavioral Health Team Members Bernard Biermann, MD, PhD Child/Adolescent Psychiatry Barbara T Felt, MD Child Behavioral Health R Van Harrison, PhD Medical Education Paramjeet K Kochhar, MD General Pediatrics Consultant Darcie-Ann Streetman, PharmD College of Pharmacy Initial Release August, 2005 (...) of child’s self-identified impression of function, both strengths and weaknesses • Clinician’s observations of child’s behavior • Physical and neurologic examination Note: From ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/HyperactivityDisorder in Children and Adolescents, American Academy of Pediatrics, Nov. 2011 Table 4. Treatment Options for ADHD For pre-school aged children, first line is behavior therapy. If not significantly improved, prescribe
found below this term in the MeSH hierarchy; [MAJR] = MeSH Major Topic; [TIAB] = Title or abstract; [TI] = Title; [AU] = Author; [TW] = Text Word; Systematic[SB] = Filter for retrieving systematic reviews; * = Truncation Search terms Items found Population: 1. “AttentionDeficit and DisruptiveBehaviorDisorders”/ 2747 2. AttentionDeficitDisorder with Hyperactivity/ 27226 3. "Attentiondeficit* ".ab,kw,ti. 27852 4. ("Attentiondeficit*" adj6 hyper*).ab,kw,ti. 24598 5. ("ADHD" or "ADDH").ab,kw,ti (...) found Population: 1. [mh “AttentionDeficit and DisruptiveBehaviorDisorders”] 2809 2. [mh “AttentionDeficitDisorder with Hyperactivity”] 2482 3. (“AttentionDeficitDisorder*”:ab,ti) 3751 4. ("Attentiondeficit*":ab,ti NEAR hyper*:ab,ti) 3529 5. (“adhd”:ti,ab,kw OR “addh”:ti,ab) 4168 6. 1 OR 2 OR 3 OR 4 OR 5 5506 7. [mh "Autistic Disorder"] 867 8. [mh "Autism Spectrum Disorder"] 1211 9. ("Autism" or Autist* or "ASD" OR "Autism spectrum*"):ti,ab 3467 10. 7 OR 8 OR 9 3523 11. 6 OR 10 8787
Occupational therapy for attention-deficit/hyperactivitydisorder (ADHD) Occupational therapy for attention-deficit/hyperactivitydisorder (ADHD) Occupational therapy for attention-deficit/hyperactivitydisorder (ADHD) HAYES, Inc Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation HAYES, Inc. Occupational therapy for attention-deficit/hyperactivitydisorder (ADHD (...) ) Lansdale: HAYES, Inc. Directory Publication. 2017 Authors' conclusions Occupational therapy (OT) for attention-deficit/hyperactivitydisorder (ADHD) encompasses a wide array of interventions, with the aim of increasing function in all aspects of life and settings (school, home, etc.). Specific interventions vary and are determined by the occupational therapist depending on the presenting problems, deficits, and the therapist's determination of the best course of treatment. OT interventions for ADHD can
examination by a physician/medical doctor - Psychological 2016 10. Bupropion for attentiondeficithyperactivitydisorder ( ADHD ) in adults. BACKGROUND: Attentiondeficithyperactivitydisorder ( ADHD ) is a prevalent neurobiological condition, characterised by behavioral and cognitive symptoms such as inattention, impulsivity and/or excessive activity. The syndrome is commonly accompanied by psychiatric comorbidities and is associated with educational and occupational underachievement.Although (...) in improving family and social relationships. On the other hand, it has frequent, sometimes severe, adverse effects. In practice, it is best to avoid guanfacine. The diagnosis of attentiondeficithyperactivitydisorder in children is based on non-specific behavioural symptoms: inattentiveness, hyperactivity and impulsiveness. The disruptive impact on family 2017 17. ADHD in Children and Adolescents ADHD in Children and Adolescents -- Clinical Recommendation Welcome Search Search Specify your search
, Starreveld JS et al. (2003) Melatonin for treatment of sleeping disorders in children with attentiondeficit/hyperactivitydisorder: a preliminary open label study. European Journal of Pediatrics 162: 554–5 van der Heijden KB, Smits MG, Someren EJ et al. (2007) Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia. Journal of the American Academy of Child and Adolescent Psychiatry 46: 233–41 Waldron D, Bramble D, Gringas P (2005) Melatonin: prescribing practices (...) , characterised by poor quality of sleep, in adults who are aged 55 years or over. Additional melatonin products are available from special-order manufacturers or specialist importing companies, or can be purchased directly online. No high-quality studies were identified that provided evidence for the efficacy of prolonged- release melatonin tablets (licensed in the UK) used off-label in children with sleep disorders and attentiondeficithyperactivitydisorder (ADHD). Limited evidence for unlicensed
of Attention-Deficit/HyperactivityDisorder in Children and Adolescents was developed by the American Academy of Pediatrics (AAP) and endorsed by the American Academy of Family Physicians (AAFP). Key Recommendations Any child 4 through 18 years of age who presents with academic or behavioral problems and symptoms of inattention, hyperactivity, or impulsivity should be evaluated for ADHD. The diagnosis of ADHD should be based on the criteria from the Diagnostic and Statistical Manual of Mental Disorders (...) medications for ADHD and may be treated with behavioral therapy. Medication doses should be titrated to achieve maximum benefit with minimum adverse effects. Access the article with full recommendation for more information on ADHD: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/HyperactivityDisorder in Children and Adolescents. * Please note that the AAP has also developed a Process of Care Supplemental Appendix document, available on the AAP website, which
Pharmacological treatment for attentiondeficithyperactivitydisorder (ADHD) in children with comorbid tic disorders. This is an update of the original Cochrane Review published in Issue 4, 2011.Attentiondeficithyperactivitydisorder (ADHD) is the most prevalent of the comorbid psychiatric disorders that complicate tic disorders. Medications commonly used to treat ADHD symptoms include stimulants such as methylphenidate and amphetamine; non-stimulants, such as atomoxetine; tricyclic (...) antidepressants; and alpha agonists. Alpha agonists are also used as a treatment for tics. Due to the impact of ADHD symptoms on the child with tic disorder, treatment of ADHD is often of greater priority than the medical management of tics. However, for many decades, clinicians have been reluctant to use stimulants to treat children with ADHD and tics for fear of worsening their tics. OBJECTIVES: To assess the effects of pharmacological treatments for ADHD in children with comorbid tic disorders on symptoms
ADHD in children and youth: Part 2?Treatment Attention-deficithyperactivitydisorder (ADHD) is a chronic neurodevelopmental disorder. Three position statements have been developed by the Canadian Paediatric Society, following systematic literature reviews. Statement objectives are to: 1) Summarize the current clinical evidence regarding ADHD, 2) Establish a standard for ADHD care, and 3) Assist Canadian clinicians in making well-informed, evidence-based decisions to enhance care of children (...) the literature, and expert consensus. Keywords: ADHD; Adverse effects; Combined interventions; Medication management
Posted: May 24, 2018 Last Verified: May 2018 Individual Participant Data (IPD) Sharing Statement: Plan to Share IPD: Undecided Layout table for additional information Studies a U.S. FDA-regulated Drug Product: No Studies a U.S. FDA-regulated Device Product: No Product Manufactured in and Exported from the U.S.: No Additional relevant MeSH terms: Layout table for MeSH terms Disease AttentionDeficitDisorder with Hyperactivity Hyperkinesis Pathologic Processes AttentionDeficit and DisruptiveBehavior (...) additive effects in improving attention in adults. However, the specific actions of these substances have not been examined in children and adolescents with attentiondeficithyperactivitydisorder (ADHD), who are characterized by impaired attention, hyperkinesia and impulsivity. Therefore, the investigators plan to study the functional activity of brains (both at rest and when performing standard tasks designed to measure attention) in children diagnosed with ADHD using functional magnetic resonance
of mental disorders, 5th ed., (DSM-5). Washington, DC: American Psychiatric Publishing; 2013. As a result, ADHD can limit academic, interpersonal, and occupational success and can also lead to greater risk-taking and accidents. Schonwald A, Lechner E. Attentiondeficit/hyperactivitydisorder: complexities and controversies. Curr Opin Pediatr. 2006;18:189-195. http://www.ncbi.nlm.nih.gov/pubmed/16601502?tool=bestpractice.com In addition, patients with ADHD are more likely to have co-existing psychiatric (...) Attentiondeficithyperactivitydisorder in children Attentiondeficithyperactivitydisorder in children - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search Attentiondeficithyperactivitydisorder in children Last reviewed: February 2019 Last updated: March 2018 Summary Common childhood-onset disorder characterised by inattention, hyperactivity, and/or impulsivity demonstrated across 2 or more settings (such as home
: No Studies a U.S. FDA-regulated Device Product: No Keywords provided by Dr Sung Min, Institute of Mental Health, Singapore: Phosphatidylserine Omega-3 Additional relevant MeSH terms: Layout table for MeSH terms Disease Autistic DisorderAttentionDeficitDisorder with Hyperactivity Hyperkinesis Autism Spectrum Disorder Pathologic Processes Child Development Disorders, Pervasive Neurodevelopmental Disorders Mental DisordersAttentionDeficit and DisruptiveBehaviorDisorders Dyskinesias Neurologic (...) Efficacy Study of Vayarin in Children With Autism and Comorbid AttentionDeficitHyperactivityDisorder (ADHD) Efficacy Study of Vayarin in Children With Autism and Comorbid AttentionDeficitHyperactivityDisorder (ADHD) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved